Evidence map›Paper›PMID 29161093›Full record

ArticleAmerican journal of respiratory and critical care medicine2018

B Cells Producing Type I IFN Modulate Macrophage Polarization in Tuberculosis.

Alan Bénard, Imme Sakwa, Pablo Schierloh, André Colom, Ingrid Mercier, Ludovic Tailleux, Luc Jouneau, Pierre Boudinot, Talal Al-Saati, Roland Lang and 10 more

Open access · greenAbstract read
In one paragraph

Article in American journal of respiratory and critical care medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 1 synthesis or guideline pooled it, 84 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Single-cell atlas of grass carp (Zoological research · 2025
    Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Host Immune Response toJournal of inflammation research · 2025
    Review
  11. Review
  12. M2 macrophages promote IL-10Immunotherapy advances · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Leishmaniasis: Immune Cells Crosstalk in Macrophage Polarization.Tropical medicine and infectious disease · 2023
    Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 11 institutions in 5 countries.

Alan Bénard1 Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, Centre National de la Recherche Scientifique (CNRS), Université Paul Sabatier, Toulouse, France.
Imme Sakwa4 Deutsches Rheuma-Forschungszentrum, a Leibniz Institute, Berlin, Germany.
Pablo Schierloh2 International Associated Laboratory CNRS "IM-TB/HIV (Immunometabolism and Macrophages in Tuberculosis/Human Immunodeficiency Virus-1 Co-infection)," Toulouse, France, and Buenos Aires, Argentina.
André Colom1 Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, Centre National de la Recherche Scientifique (CNRS), Université Paul Sabatier, Toulouse, France.
Ingrid Mercier1 Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, Centre National de la Recherche Scientifique (CNRS), Université Paul Sabatier, Toulouse, France.
Ludovic Tailleux7 Unit of Mycobacterial Genetics and.
Luc Jouneau9 Virologie et Immunologie Moléculaires, INRA, Jouy-en-Josas, France.
Pierre Boudinot9 Virologie et Immunologie Moléculaires, INRA, Jouy-en-Josas, France.
Talal Al-Saati10 Institut National de la Santé et de la Recherche Médicale (INSERM)/Université Paul Sabatier/École Nationale Vétérinaire de Toulouse/Centre Régional d'Exploration Fonctionnelle et Ressources Expérimentales, Service d'Histopathologie, Centre Hospitalier Universitaire, Purpan, Toulouse, France.
Roland Lang11 Institute of Clinical Microbiology, Immunology, and Hygiene, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.
Jan Rehwinkel12 Radcliffe Department of Medicine, Medical Research Council Human Immunology Unit, Medical Research Council Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom.
Andre G Loxton13 South African Medical Research Council Centre for Tuberculosis Research, Department of Science and Technology/National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research, Division of Molecular Biology and Human Genetics, Stellenbosch University, Cape Town, South Africa.
Stefan H E Kaufmann14 Department of Immunology, Max Planck Institute of Infection Biology, Berlin, Germany.
Véronique Anton-Leberre6 Laboratoire d'Ingénierie des Systèmes Biologiques et des Procédés, Université de Toulouse, CNRS, Institut National de la Recherche Agronomique (INRA), Institut National des Sciences Appliquées, Toulouse, France.
Anne O'Garra15 Division of Immunoregulation, Medical Research Council, National Institute for Medical Research, London, United Kingdom.
Maria Del Carmen Sasiain2 International Associated Laboratory CNRS "IM-TB/HIV (Immunometabolism and Macrophages in Tuberculosis/Human Immunodeficiency Virus-1 Co-infection)," Toulouse, France, and Buenos Aires, Argentina.
Brigitte Gicquel9 Virologie et Immunologie Moléculaires, INRA, Jouy-en-Josas, France.
Simon Fillatreau4 Deutsches Rheuma-Forschungszentrum, a Leibniz Institute, Berlin, Germany.
Olivier Neyrolles1 Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, Centre National de la Recherche Scientifique (CNRS), Université Paul Sabatier, Toulouse, France.
Denis Hudrisier1 Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, Centre National de la Recherche Scientifique (CNRS), Université Paul Sabatier, Toulouse, France.
Centre National de la Recherche Scientifique · FRVirologie et Immunologie Moléculaires · FRDélégation Paris 5 · FRFriedrich-Alexander-Universität Erlangen-Nürnberg · DEGerman Rheumatism Research Centre · DEImperial College London · GBInstitut Pasteur · FRMax Planck Institute for Infection Biology · DESouth African Medical Research Council · ZAUniversité Toulouse III - Paul Sabatier · FRUniversity of Oxford · GB

Funding

Cancer Research UK FC001126European Research Council 294682Medical Research Council FC001126Medical Research Council MC_U117565642Medical Research Council MC_UU_00008/8Medical Research Council MC_UU_12010/8Medical Research Council MR/U117565642/1Wellcome TrustWellcome Trust FC001126
6 · The paper itself

Abstract

rationaleIn addition to their well-known function as antibody-producing cells, B lymphocytes can markedly influence the course of infectious or noninfectious diseases via antibody-independent mechanisms. In tuberculosis (TB), B cells accumulate in lungs, yet their functional contribution to the host response remains poorly understood.

objectivesTo document the role of B cells in TB in an unbiased manner.

methodsWe generated the transcriptome of B cells isolated from Mycobacterium tuberculosis (Mtb)-infected mice and validated the identified key pathways using in vitro and in vivo assays. The obtained data were substantiated using B cells from pleural effusion of patients with TB. MEASUREMENTS AND MAIN

resultsB cells isolated from Mtb-infected mice displayed a STAT1 (signal transducer and activator of transcription 1)-centered signature, suggesting a role for IFNs in B-cell response to infection. B cells stimulated in vitro with Mtb produced type I IFN, via a mechanism involving the innate sensor STING (stimulator of interferon genes), and antagonized by MyD88 (myeloid differentiation primary response 88) signaling. In vivo, B cells expressed type I IFN in the lungs of Mtb-infected mice and, of clinical relevance, in pleural fluid from patients with TB. Type I IFN expression by B cells induced an altered polarization of macrophages toward a regulatory/antiinflammatory profile in vitro. In vivo, increased provision of type I IFN by B cells in a murine model of B cell-restricted Myd88 deficiency correlated with an enhanced accumulation of regulatory/antiinflammatory macrophages in Mtb-infected lungs.

conclusionsType I IFN produced by Mtb-stimulated B cells favors macrophage polarization toward a regulatory/antiinflammatory phenotype during Mtb infection.

Indexed as

AnimalsB-LymphocytesDisease Models, AnimalHumansInterferon Type ILungMacrophagesMiceMice, Inbred C57BLMycobacterium tuberculosisSignal TransductionSpleenTuberculosisInterferon Type IB lymphocytesIFNmacrophagestuberculosis

Identifiers

PMID29161093
PMCPMC5855072
OpenAlexW2769767537

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.